# FDA recall D-0593-2017

> **Synergy Rx** · Class II · drug recall initiated 2017-02-10.

## Product

LIDOCAINE CREAM in all strengths including: 5%, 8%, 23%, 30%,   LIDOCAINE / PRILOCAINE / MELYLEPHRINE 15% / 5% / 0.5% CREAM,   LIDOCAINE / PRILOCAINE / MELYLEPHRINE 15% / 5% / 0.5% OINTMENT  LIDOCAINE 23%/ TETRACAINE 7% CREAM,  LIDOCAINE 23%/TETRACAINE 7% OINTMENT, LIDOCAINE 23%/TETRACAINE 7%/PRILOCAONE 2.5%, LIDOCAINE 24%/PRILOCAINE 26% OINTMENT, LIDOCAINE 30%/TETRACAINE 4% /PRILOCAINE 2%, LIDOCAINE 30%/PHENYLEPHRINE 0.25%, LIDOCAINE 30%/ TETRACAINE 10%, MELYLEPHRINE 4%, LIDOCAINE 30%/TETRACAINE 4%/PRILOCAINE, LIDOCAINE 7%/TETRACAINE 7% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676

## Reason for recall

Lack of Assurance of Sterility: There are also CGMP Deviations.

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0593-2017
- **Recalling firm:** Synergy Rx
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-02-10
- **Report date:** 2017-03-22
- **Termination date:** 2017-05-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** San Diego, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0593-2017

## Citation

> AI Analytics. FDA recall D-0593-2017. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0593-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*